Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00531037
Other study ID # Nature - RGST01
Secondary ID RGST01
Status Completed
Phase N/A
First received September 17, 2007
Last updated November 10, 2017
Start date June 2007
Est. completion date December 2011

Study information

Verified date November 2017
Source LivaNova
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Observational study to assess AV block incidence and their evolution according to paroxysmal atrial arrhythmia.


Recruitment information / eligibility

Status Completed
Enrollment 1440
Est. completion date December 2011
Est. primary completion date December 2011
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Sinus Node Disease

- Brady-Tachy Syndrome

- Suspected or documented paroxysmal AVB

Exclusion Criteria:

- Permanent high degree AVB

- Contra indication to the SafeR pacing mode

- PR higher than 350 ms

Study Design


Related Conditions & MeSH terms

  • Patients Implanted With a Pacemaker

Locations

Country Name City State
Belgium Az St- Blasius Dendermonde
Belgium Ch de Huy HUY
Belgium Heilig Hart Ziekenhuis MOL MOL
Canada Hospital Hamilton Hamilton
Canada Niagara Health System Niagara
Denmark Bispebjerg Hospital Bispebjerg
Denmark HELLERUP Gentofte Hospital
France Clinique Esquirol Agen
France CH Albi Albi
France Clinique Claude Bernard Albi
France CH ALES Ales
France Clinique Bonnefond Ales
France Cabinet Prive Annecy
France Clinique Aressy Aressy
France CH AUCH Auch
France Clinique Paulmy Bayonne
France Ch Beauvais Beauvais
France Clinique St Vincent Besancon
France Ch Beziers Beziers
France Clinique Aguilera Biarritz
France Chu Pessac Bordeaux
France Clinique Des Pins Francs Bordeaux
France Ch Boulogne Boulogne Sur Mer
France Chu Brest Brest
France CH BRIVE Brive
France Ch Calais Calais
France Clinique Des 2 Caps Calais
France Ch Carcassonne Carcassonne
France Chu Ceret Ceret
France Ch Chalons Chalons En Champagne
France Clinique Bon Secours Chatellerault
France Ch Chaumont Chaumont
France Ch Cherbourg Cherbourg
France Ch Colmar Colmar
France Cabinet Cardiologie Creutzwald Creutzwald
France Polyclinique Du Parc Croix
France CH DINAN Dinan
France CH DOLE Dole
France CH DOUAI Douai
France Ch Douarnenez Douarnenez
France Polyclinique Notre Dame Draguignan
France Hôpital Emile Roux Eaubonne
France Centre Cardiologique D'Evecquemont Evecquemont
France Hôpital D'Evreux Evreux
France Ch Firminy Firminy
France Ch Forbach Forbach
France Ch Freyming Freyming Merlebach
France CH GAP GAP
France Ch Lannion Lannion
France Cmc Parly Ii Le Chesnay
France Ch Le Havre Le Havre
France Chu Le Havre Le Havre
France Hôpital Cardiologique Lyon
France Chu La Timone Marseille
France Hôpital Nord Marseille
France Chg Martigues Martigues
France Institut Hospitalier Jacques Cartier Massy
France Hôpital Ste Blandine Metz
France Clinique Pont Chaume Montauban
France Hôpital Le Raincy Monfermeil Montfermeil
France Chu Montpellier Montpellier
France Clinique Plein Ciel Mougins
France Ch Moulins Moulins
France Clinique Du Diaconnat Mulhouse
France Centre Chirurgical Ambroise Pare Neuilly Sur Seine
France Ch Nevers Nevers
France Clinique Des Fleurs Ollioules
France Ch Orange Orange
France Clinique Bizet Paris
France Clinique Parc Monceau Paris
France Hôpital Val de Grâce Paris
France CHU PAU PAU
France Ch Perpignan Perpignan
France Chu Poitiers Poitiers
France Centre Medico Chirurgical de L'Europe PORT Marly
France Hôpital Prive Claude Galien Quincy Sous Senart
France Clinique Pasteur Ris Orangis
France CH RODEZ Rodez
France Clinique St Hilaire Rouen Rouen
France Polyclinique de Montier La Celle Saint André Les Vergers
France Clinique Notre Dame Saint Die Des Vosges
France Hôpital Prive Nord Parisien Sarcelles
France Centre Cardiologique Du Nord St Denis
France Ch St Malo St Malo
France Cmc Ste Feyre STE Feyre
France Clinique St Gatien Tours
France Clinique Vauban Valenciennes
Germany Erzgebirgsklinikum ANNABERG Annaberg
Germany Schade Stolz Rötech Berlin
Germany Klinikum Bogenhausen Bogenhausen
Germany Klinikum Dresden Dresden
Germany PRAXIS Dr Subin und Lutter Hamburg
Italy Hospital Montebelluna Montebelluna
Italy Hospital Negrar Negrar
Italy Casa di Cura Pederzoli Peschiera del Garda
Japan Kanagawa Cardiov. and Respiratory Center Kanagawa
Japan Kokura Memorial Hospital Kokura
Japan Konan St Hill Hospital Konan
Japan Yokosuka Kyosai General Hospital Kyosai
Japan Mie University Hospital MIE
Japan Nara Hospital, Kinki University School of Medicine Nara
Japan Ogikubo Hospital Ogikubo
Japan Saiseikai Noe Hospital Saiseikai NOE
Japan Tokai University School of Medicine Tokai
Japan Tokio Metropolitan Geriatric Hospital Tokio
Japan Yokohama City University Hospital Yokohama
Korea, Republic of Seoul National University Hospital Seoul
Portugal Hospital Garcia Orta Almada
Portugal Hospital de Santa Cruz Carnaxide Lisboa
Portugal Hospital Central Faro Faro
Portugal Hospital Egas Moniz Lisboa
Portugal Hospital Santa Maria Lisboa
Portugal Hospital Santa Marta Lisboa
Portugal Hospital São Francisco Xavier Lisboa
Portugal Hospital Distrital de Santarém Santarem
Spain Hospital Marina Alta Denia
Spain Hospital General de Elda Elda
Spain Hospital de Cabuenes Gijon
Spain Hospital Vega Baja Orihuela
Spain Hospital Arnau de Vilanova Valencia
Spain Hospital La Fe Valencia
Spain Meixoeiro Vigo
United States Baptist Princeton Birmingham Birmingham Alabama
United States Cardiovascular Assoc. Of Mesa Mesa Arizona
United States University of Mississippi Medical Center Mississippi Mississippi
United States Piedmont hospital Piedmont Georgia
United States O'Connor Hospital San Jose San Jose California
United States Tennessee Valley Sheffield Sheffield Alabama
United States St. Francis Hospital Tulsa Tulsa Oklahoma

Sponsors (1)

Lead Sponsor Collaborator
LivaNova

Countries where clinical trial is conducted

United States,  Belgium,  Canada,  Denmark,  France,  Germany,  Italy,  Japan,  Korea, Republic of,  Portugal,  Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary High degree AV blocks 2 years